SARS-CoV-2主蛋白酶6YNQ潜在类黄酮抑制剂的分子对接研究

Q3 Medicine
Sumit Arora , Govind Lohiya , Keshav Moharir , Sapan Shah , Subhash Yende
{"title":"SARS-CoV-2主蛋白酶6YNQ潜在类黄酮抑制剂的分子对接研究","authors":"Sumit Arora ,&nbsp;Govind Lohiya ,&nbsp;Keshav Moharir ,&nbsp;Sapan Shah ,&nbsp;Subhash Yende","doi":"10.1016/j.dcmed.2020.12.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for coronavirus disease 2019 (COVID-19), is responsible for the recent global pandemic. As there are no effective drugs or vaccines available for SARS-CoV-2, we investigated the potential of flavonoids against SARS-CoV-2 main protease 6YNQ.</p></div><div><h3>Methods</h3><p><em>In silico</em> molecular simulation study against SARS-CoV-2 main protease 6YNQ.</p></div><div><h3>Results</h3><p>Among the 21 selected flavonoids, rutin demonstrated the highest binding energy (− 8.7 kcal/mol) and displayed perfect binding with the catalytic sites.</p></div><div><h3>Conclusions</h3><p>Our study demonstrates the inhibitory potential of flavonoids against SARS-CoV-2 main protease 6YNQ. These computational simulation studies support the hypothesis that flavonoids might be helpful for the treatment of COVID-19.</p></div>","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dcmed.2020.12.003","citationCount":"27","resultStr":"{\"title\":\"Identification of Potential Flavonoid Inhibitors of the SARS-CoV-2 Main Protease 6YNQ: A Molecular Docking Study\",\"authors\":\"Sumit Arora ,&nbsp;Govind Lohiya ,&nbsp;Keshav Moharir ,&nbsp;Sapan Shah ,&nbsp;Subhash Yende\",\"doi\":\"10.1016/j.dcmed.2020.12.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for coronavirus disease 2019 (COVID-19), is responsible for the recent global pandemic. As there are no effective drugs or vaccines available for SARS-CoV-2, we investigated the potential of flavonoids against SARS-CoV-2 main protease 6YNQ.</p></div><div><h3>Methods</h3><p><em>In silico</em> molecular simulation study against SARS-CoV-2 main protease 6YNQ.</p></div><div><h3>Results</h3><p>Among the 21 selected flavonoids, rutin demonstrated the highest binding energy (− 8.7 kcal/mol) and displayed perfect binding with the catalytic sites.</p></div><div><h3>Conclusions</h3><p>Our study demonstrates the inhibitory potential of flavonoids against SARS-CoV-2 main protease 6YNQ. These computational simulation studies support the hypothesis that flavonoids might be helpful for the treatment of COVID-19.</p></div>\",\"PeriodicalId\":33578,\"journal\":{\"name\":\"Digital Chinese Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.dcmed.2020.12.003\",\"citationCount\":\"27\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Digital Chinese Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2589377720300677\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Digital Chinese Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589377720300677","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 27

摘要

目的严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)是2019冠状病毒病(COVID-19)的病原体,是最近全球大流行的罪魁祸首。由于没有有效的药物或疫苗可用于SARS-CoV-2,我们研究了黄酮类化合物对SARS-CoV-2主要蛋白酶6YNQ的潜力。方法对SARS-CoV-2主要蛋白酶6YNQ进行硅分子模拟研究。结果在所选的21种黄酮类化合物中,芦丁的结合能最高(- 8.7 kcal/mol),与催化位点结合良好。结论黄酮类化合物对SARS-CoV-2主要蛋白酶6YNQ具有抑制作用。这些计算模拟研究支持了类黄酮可能有助于治疗COVID-19的假设。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Identification of Potential Flavonoid Inhibitors of the SARS-CoV-2 Main Protease 6YNQ: A Molecular Docking Study

Objective

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for coronavirus disease 2019 (COVID-19), is responsible for the recent global pandemic. As there are no effective drugs or vaccines available for SARS-CoV-2, we investigated the potential of flavonoids against SARS-CoV-2 main protease 6YNQ.

Methods

In silico molecular simulation study against SARS-CoV-2 main protease 6YNQ.

Results

Among the 21 selected flavonoids, rutin demonstrated the highest binding energy (− 8.7 kcal/mol) and displayed perfect binding with the catalytic sites.

Conclusions

Our study demonstrates the inhibitory potential of flavonoids against SARS-CoV-2 main protease 6YNQ. These computational simulation studies support the hypothesis that flavonoids might be helpful for the treatment of COVID-19.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Digital Chinese Medicine
Digital Chinese Medicine Medicine-Complementary and Alternative Medicine
CiteScore
1.80
自引率
0.00%
发文量
126
审稿时长
63 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信